annual CFF:
$253.89M+$121.36M(+91.57%)Summary
- As of today (September 16, 2025), WVE annual cash flow from financing activities is $253.89 million, with the most recent change of +$121.36 million (+91.57%) on December 31, 2024.
- During the last 3 years, WVE annual CFF has risen by +$198.06 million (+354.77%).
- WVE annual CFF is now at all-time high.
Performance
WVE Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$11.98M+$7.83M(+188.37%)Summary
- As of today (September 16, 2025), WVE quarterly cash flow from financing activities is $11.98 million, with the most recent change of +$7.83 million (+188.37%) on June 30, 2025.
- Over the past year, WVE quarterly CFF has increased by +$11.40 million (+1958.75%).
- WVE quarterly CFF is now -94.20% below its all-time high of $206.71 million, reached on September 30, 2024.
Performance
WVE quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$255.74M+$11.40M(+4.67%)Summary
- As of today (September 16, 2025), WVE TTM cash flow from financing activities is $255.74 million, with the most recent change of +$11.40 million (+4.67%) on June 30, 2025.
- Over the past year, WVE TTM CFF has increased by +$145.62 million (+132.24%).
- WVE TTM CFF is now -18.88% below its all-time high of $315.28 million, reached on September 30, 2024.
Performance
WVE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
WVE Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +91.6% | +1958.8% | +132.2% |
| 3 y3 years | +354.8% | -81.6% | +136.6% |
| 5 y5 years | +54.4% | +6.3% | +1791.5% |
WVE Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +354.8% | -94.2% | +2721.9% | -18.9% | +589.3% |
| 5 y | 5-year | at high | +354.8% | -94.2% | +2721.9% | -18.9% | +1791.5% |
| alltime | all time | at high | +6814.2% | -94.2% | +1208.7% | -18.9% | >+9999.0% |
WVE Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $11.98M(+188.4%) | $255.74M(+4.7%) |
| Mar 2025 | - | $4.16M(-87.4%) | $244.34M(-4.1%) |
| Dec 2024 | $253.89M(+91.6%) | $32.89M(-84.1%) | $254.69M(-19.2%) |
| Sep 2024 | - | $206.71M(>+9900.0%) | $315.28M(+186.3%) |
| Jun 2024 | - | $582.00K(-96.0%) | $110.12M(-1.1%) |
| Mar 2024 | - | $14.51M(-84.5%) | $111.29M(-15.6%) |
| Dec 2023 | $132.53M(+97.3%) | $93.48M(+5932.9%) | $131.83M(+237.1%) |
| Sep 2023 | - | $1.55M(-11.5%) | $39.11M(+5.4%) |
| Jun 2023 | - | $1.75M(-95.0%) | $37.10M(-63.1%) |
| Mar 2023 | - | $35.05M(+4559.4%) | $100.52M(+50.5%) |
| Dec 2022 | $67.19M(+20.3%) | $752.30K(-264.6%) | $66.78M(-32.9%) |
| Sep 2022 | - | -$457.00K(-100.7%) | $99.51M(-7.9%) |
| Jun 2022 | - | $65.17M(+4852.3%) | $108.08M(+125.4%) |
| Mar 2022 | - | $1.32M(-96.1%) | $47.96M(-13.3%) |
| Dec 2021 | $55.83M(-63.9%) | $33.47M(+312.2%) | $55.28M(+128.7%) |
| Sep 2021 | - | $8.12M(+60.9%) | $24.18M(-84.9%) |
| Jun 2021 | - | $5.05M(-41.6%) | $160.12M(-3.7%) |
| Mar 2021 | - | $8.64M(+265.0%) | $166.35M(+5.1%) |
| Dec 2020 | $154.54M(-6.0%) | $2.37M(-98.4%) | $158.32M(+0.2%) |
| Sep 2020 | - | $144.07M(+1177.8%) | $158.00M(+1068.6%) |
| Jun 2020 | - | $11.27M(+1736.3%) | $13.52M(+754.8%) |
| Mar 2020 | - | $614.00K(-70.0%) | $1.58M(-99.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $164.40M(+152.6%) | $2.04M(-595.6%) | $164.51M(+0.8%) |
| Sep 2019 | - | -$412.40K(-37.9%) | $163.14M(-0.5%) |
| Jun 2019 | - | -$663.90K(-100.4%) | $164.03M(-27.4%) |
| Mar 2019 | - | $163.55M(>+9900.0%) | $225.88M(+253.6%) |
| Dec 2018 | $65.09M(-31.0%) | $666.00K(+37.9%) | $63.87M(+0.8%) |
| Sep 2018 | - | $482.90K(-99.2%) | $63.35M(-1.6%) |
| Jun 2018 | - | $61.19M(+3881.0%) | $64.41M(-34.0%) |
| Mar 2018 | - | $1.54M(+968.1%) | $97.55M(+1.4%) |
| Dec 2017 | $94.37M(+224.1%) | $143.90K(-90.7%) | $96.21M(+1.3%) |
| Sep 2017 | - | $1.54M(-98.4%) | $94.98M(+1.4%) |
| Jun 2017 | - | $94.33M(>+9900.0%) | $93.63M(+226.2%) |
| Mar 2017 | - | $190.00K(-117.6%) | $28.71M(+0.7%) |
| Dec 2016 | $29.12M(-83.4%) | -$1.08M(-676.1%) | $28.50M(-78.1%) |
| Sep 2016 | - | $187.60K(-99.4%) | $129.93M(-32.0%) |
| Jun 2016 | - | $29.41M(<-9900.0%) | $190.95M(+18.2%) |
| Mar 2016 | - | -$16.00K(-100.0%) | $161.56M(-6.7%) |
| Dec 2015 | $175.59M(+3025.0%) | $100.35M(+63.9%) | $173.20M(+137.7%) |
| Sep 2015 | - | $61.21M(>+9900.0%) | $72.86M(+525.6%) |
| Jun 2015 | - | $15.00K(-99.9%) | $11.65M(+0.1%) |
| Mar 2015 | - | $11.63M | $11.63M |
| Dec 2014 | $5.62M(+53.0%) | - | - |
| Dec 2013 | $3.67M | - | - |
FAQ
- What is Wave Life Sciences Ltd. annual cash flow from financing activities?
- What is the all time high annual CFF for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. annual CFF year-on-year change?
- What is Wave Life Sciences Ltd. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. quarterly CFF year-on-year change?
- What is Wave Life Sciences Ltd. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. TTM CFF year-on-year change?
What is Wave Life Sciences Ltd. annual cash flow from financing activities?
The current annual CFF of WVE is $253.89M
What is the all time high annual CFF for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high annual cash flow from financing activities is $253.89M
What is Wave Life Sciences Ltd. annual CFF year-on-year change?
Over the past year, WVE annual cash flow from financing activities has changed by +$121.36M (+91.57%)
What is Wave Life Sciences Ltd. quarterly cash flow from financing activities?
The current quarterly CFF of WVE is $11.98M
What is the all time high quarterly CFF for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high quarterly cash flow from financing activities is $206.71M
What is Wave Life Sciences Ltd. quarterly CFF year-on-year change?
Over the past year, WVE quarterly cash flow from financing activities has changed by +$11.40M (+1958.75%)
What is Wave Life Sciences Ltd. TTM cash flow from financing activities?
The current TTM CFF of WVE is $255.74M
What is the all time high TTM CFF for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high TTM cash flow from financing activities is $315.28M
What is Wave Life Sciences Ltd. TTM CFF year-on-year change?
Over the past year, WVE TTM cash flow from financing activities has changed by +$145.62M (+132.24%)